Anticorps Polyclonal de lapin anti-MAZ

MAZ Polyclonal Antibody for WB, IF/ICC, ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, souris

Applications

WB, IHC, IF/ICC, ChIP, ELISA

Conjugaison

Non conjugué

Publications(6)

N° de cat : 21068-1-AP

Synonymes

MAZI, Myc-associated zinc finger protein, Pur 1, PUR1, Pur-1



Applications testées

Résultats positifs en WBcellules HeLa, tissu pulmonaire de souris
Résultats positifs en IF/ICCcellules A431,

Dilution recommandée

ApplicationDilution
Western Blot (WB)WB : 1:500-1:1000
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

21068-1-AP cible MAZ dans les applications de WB, IHC, IF/ICC, ChIP, ELISA et montre une réactivité avec des échantillons Humain, souris

Réactivité Humain, souris
Réactivité citéeHumain, souris
Hôte / Isotype Lapin / IgG
Clonalité Polyclonal
Type Anticorps
Immunogène MAZ Protéine recombinante Ag15200
Nom complet MYC-associated zinc finger protein (purine-binding transcription factor)
Masse moléculaire calculée 477 aa, 49 kDa
Poids moléculaire observé 49-55 kDa
Numéro d’acquisition GenBankBC041629
Symbole du gène MAZ
Identification du gène (NCBI) 4150
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par affinité contre l'antigène
Tampon de stockage PBS with 0.02% sodium azide and 50% glycerol
Conditions de stockageStocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA.

Informations générales

Myc-associated zinc finger protein (MAZ) is a six zinc finger protein with a G-rich binding motif. MAZ is often found at genomic binding sites adjacent to CTCF, a protein which affects large-scale genome organization through its interaction with cohesin (PMID: 33558242). MAZ is widely expressed in most human tissues, such as heart, lung, brain, liver, placenta, testis, colon, peripheral blood leukocytes, skeletal muscle, thymus, pancreas, prostate, thyroid, and adrenal gland (PMID: 35098656). In cancer, MAZ has been proved to be highly expressed in malignant tumors, and to promote cancer progression and metastasis by regulating the transcription of downstream target genes through directly binding with target gene promoters or synergistic action with other transcription factors.

Protocole

Product Specific Protocols
WB protocol for MAZ antibody 21068-1-APDownload protocol
IF protocol for MAZ antibody 21068-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Oxid Med Cell Longev

TUG1/MAZ/FTH1 Axis Attenuates the Antiglioma Effect of Dihydroartemisinin by Inhibiting Ferroptosis

Authors - Hailong Gong
mouseIF

Cell Rep

Multi-omics profiling visualizes dynamics of cardiac development and functions

Authors - Yayun Gu
humanWB

Genomics

PLOD1 promote proliferation and migration with glycolysis via the Wnt/β-catenin pathway in THCA

Authors - Wei Cong
humanWB

Alzheimers Res Ther

Uncovering the epigenetic regulatory clues of PRRT1 in Alzheimer's disease: a strategy integrating multi-omics analysis with explainable machine learning

Authors - Fang Wang
humanWB,IHC,ChIP

Commun Biol

Molecular mechanisms of MAZ targeting up-regulation of NDUFS3 expression to promote malignant progression in melanoma

Authors - Yu Feng
humanWB

Oncogene

YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy

Authors - Hongxin Huang
  • KD Validated
{{ptg:RelatedPrimaryAntibodies}}